FDA Inspection 967701 — Central California Blood Center

Central California Blood Center — FEI 3002963670

The FDA completed an inspection of Central California Blood Center on April 18, 2016 in Fresno, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 18, 2016
Fiscal Year
2016
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Fresno, CA (United States)